期刊文献+

慢性阻塞性肺疾病诊治进展

原文传递
导出
摘要 慢性阻塞性肺疾病(Chronicobstructivepulmonarydisease,COPD)是一种以气流受限为特征的肺部疾病,气流受限不完全可逆,呈进行性发展,是可以预防和治疗的疾病。COPD主要累及肺部,但也可引起肺外各器官的损害。慢性阻塞性肺疾病(COPD)由于其患病人数多,死亡率高,社会经济负担重,已成为一个重要的公共卫生问题。COPD目前居全球死亡原因的第4位。
出处 《按摩与康复医学》 2011年第12期87-88,共2页 Chinese Manipulation and Rehabilitation Medicine
  • 相关文献

参考文献9

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 2Rabe KF, Hurd S,Anzueto A,et al. Global strategy for the diagno- sis, management, and prevention of chronic obstructive pulmoary disease :GOLD executive summary[J]. Am J Respir Crit Care Med, 2007,176(6) : 532.
  • 3Hill A T,Bayley D,Stockley R A. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis[J]. Am J Respir Crit Care Med,1999,160(3) :893-898.
  • 4Nannini L J Jr, Flores D M. Bronchodilator effect of zafirlukast in subjects with chronic obstructive pulmonary disease [J ]. Pulm Pharmacol Ther, 2003,16(5) :307-311.
  • 5Hay D W, Sarau H M. Interleukin-8 receptor antagonists in pul- monary diseases[J]. Curr Opin Pharmacol,2001,1(3) :242-247.
  • 6Lundblad L K,Thompson Figueroa J, Leclair T, et al. Tumor nec- rosis factor- alpha over- expression in lung disease: a single cause behind a complex phenotype[J]. Am J Respir Crit Care Med,2005, 171(12) : 1363- 1370.
  • 7Rabinowitz M H,Andrews R C,Becherer J D,et al. Design of se- lective and soluble inhibitors of tumor necrosis factor-alpha con- verting enzyme (TACE) [J]. J Med Chem, 2001, 44 (24): 4252 -4267.
  • 8van Driel M F. Phosphodiesterase inhibitors:effectiveness and new applications [ J ]. Ned Tijdschr Geneeskd, 2006, 150 ( 29 ) : 1613-1616.
  • 9Celli B R, MacNee W, ATS/ERS Task Force. Standards for the di- agnosis and treatment of patients with COPD. a summary of the ATS/ERS position paper [J]. Eur Respir J,2004,23.

二级参考文献7

共引文献8234

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部